This week's Fierce Biotech is brought to you by Vineti.

Trouble viewing? Click here.


Vineti - In unpredictable times, advanced therapy clinical trial strategies matter more than ever
PTM EssentialsTM

Now available, a new accelerator for advanced therapy clinical trials

Cell and gene therapy clinical trials are advancing transformative therapeutics — and face the most complex operations in medicine. You need technology infrastructure as innovative as your science. Now, PTM Essentials™ is here to help. Developed by Vineti, the leader in digital solutions for cell and gene therapy orchestration, PTM Essentials™ allows for fast clinical study implementation, a quicker path to approval, built in standards, affordability, and flexibility to meet the shifting needs of patients and healthcare providers — all while supporting operations, quality, and safety.

To help you develop strategies to solve clinical trial challenges, our latest complimentary Advanced Therapy Guide provides an overview of common operational obstacles — and proven solutions — in cell and gene therapy clinical trials. Download the guide now, or talk with us about your advanced therapy clinical trial. We are here to partner with you to make progress on behalf of patients.

Download the guide

facebookWebsiteLinkedIntwitter

Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact aalcover@questex.com or call 202-824-5074.



You are currently subscribed as newsletter@newslettercollector.com.
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Questex, LLC
685 3rd Avenue, 21st Floor  
New York, NY 10017